Famciclovir API Market 2020 Segmentation and Analysis by Recent Trends and Forecast to 2025 | Haihang, Changzhou Kony Pharma, Teva, Chongqing Shenghuaxi Pharma, Aurobindo Pharma, Cipla

The growing demand for Famciclovir API has provided a major boost to the Global Famciclovir API Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2025.

Global Famciclovir API Market overview:

Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster. It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir. The Global Famciclovir API Market is segmented on the basis of Product Type, Application, End Use Industry and Region. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/276368 .

On the Basis of Product Type segment, the Famciclovir API Market is sub segmented into Purity, 99% and Purity, 98%. Based on End Use Industry segment, the Famciclovir API Market is segmented as Tablet Product and Capsule Product.

There are several manufacturers of Famciclovir API in Europe and North America. In North America, the demand for Famciclovir API is primarily driven by the Chemical and Advanced Material sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Famciclovir API Market Report 2020” @ https://www.businessindustryreports.com/buy-now/276368/single .

Top Industry News:

Cipla launches ‘ELIFast’ (IgG ELISA test) for COVID-19 antibody detection on 28 October, 2020 -- Cipla Limited referred to as “Cipla,” today announced the commercialisation of antibody detection kits for COVID-19 in India. In partnership with KARWA Ltd. under the technology transfer from the Indian Council of Medical Research (ICMR).

As part of this collaborative effort, Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA Ltd. ICMR has provided the requisite technological know-how and process for developing the test kits to the approved manufacturers. The product will be marketed under the brand name ‘ELIFast’. Cipla’s expansive distribution network will help in ensuring the seamless supply of kits across the country. Supply will be undertaken through the channels approved by ICMR, to ensure equitable access.

IgG Antibody tests identify the immune status of the individuals to the COVID-19 infection. ICMR has recommended these tests for conducting sero-surveillance. Sero-surveillance may help in determining the burden of COVID-19 at the community level and monitor the trends in the transmission of SARS-CoV-2 infection.

ELIfast has been validated and approved by ICMR and the National Institute of Virology (NIV), Pune. It is found to have specificity and sensitivity of 99.33% and 92% respectively. The kit is user friendly with a simple protocol with ready-to-use reagents and is compatible with common ELISA equipment.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/276368 .

Major Key Players:

Some of the Famciclovir API Market manufacturers involved in the market are Haihang Industry, Manus Aktteva Biopharma, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Cipla, Hanways Chempharm Co. in World, effective mergers are some of the strategies adopted by the Famciclovir API Market manufacturers. New product launches and continuous technological innovations are the Famciclovir API Market strategies adopted by the major players.

Table of Contents:

1 Famciclovir API Product Definition
2 Global Famciclovir API Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Famciclovir API Shipments
2.2 Global Manufacturer Famciclovir API Business Revenue
2.3 Global Famciclovir API Market Overview
2.4 COVID-19 Impact on Famciclovir API Industry
3 Manufacturer Famciclovir API Business Introduction
3.1 Haihang Industry Famciclovir API Business Introduction
3.1.1 Haihang Industry Famciclovir API Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Haihang Industry Famciclovir API Business Distribution by Region
3.1.3 Haihang Industry Interview Record
3.1.4 Haihang Industry Famciclovir API Business Profile
3.1.5 Haihang Industry Famciclovir API Product Specification
3.2 Manus Aktteva Biopharma Famciclovir API Business Introduction
3.2.1 Manus Aktteva Biopharma Famciclovir API Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Manus Aktteva Biopharma Famciclovir API Business Distribution by Region
3.2.3 Interview Record
3.2.4 Manus Aktteva Biopharma Famciclovir API Business Overview
3.2.5 Manus Aktteva Biopharma Famciclovir API Product Specification
3.3 Changzhou Kony Pharma Co Famciclovir API Business Introduction
3.3.1 Changzhou Kony Pharma Co Famciclovir API Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Changzhou Kony Pharma Co Famciclovir API Business Distribution by Region
3.3.3 Interview Record
3.3.4 Changzhou Kony Pharma Co Famciclovir API Business Overview
3.3.5 Changzhou Kony Pharma Co Famciclovir API Product Specification
3.4 Teva Pharmaceutical Industries Famciclovir API Business Introduction
3.5 Chongqing Shenghuaxi Pharma Famciclovir API Business Introduction
3.6 Aurobindo Pharma Limited Famciclovir API Business Introduction
……

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.